NewGenIvf Group annual return on equity
2023
2024
2025
NewGenIvf Group Return on Equity (ROE) Growth & History (NIVF)
NewGenIvf Group's return on equity was 77.23% for fiscal 2025.
View full NewGenIvf Group company overviewNewGenIvf Group annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 77.23% | +116.28 pp |
| 2024 | 2024-12-31 | −39.05% | −45.11 pp |
| 2023 | 2023-12-31 | 6.06% | — |
NewGenIvf Group quarterly return on equity
Q4.24
Q3.25
Q4.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −27.39% | −19.33 pp |
| Q3 2025 | 2025-09-30 | 118.78% | — |
| Q4 2024 | 2024-12-31 | −8.06% | — |
NewGenIvf Group return on equity trends
Between the periods ended 2023-12-31 and 2025-12-31, NewGenIvf Group's return on equity increased from 6.06% to 77.23%, a change of +71.18 percentage points. The latest reported quarter, Q4 2025, shows −27.39%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewGenIvf Group source filings ↗